Chemed (CHE) Change in Accured Expenses (2009 - 2026)

Chemed (CHE) has reported Change in Accured Expenses for 18 consecutive years, with $6.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 605.47% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $16.2 million (up 56.08% YoY), while the FY2025 annual figure was $10.4 million, down 54.18% from the prior year.
• Change in Accured Expenses came in at $6.7 million for Q1 2026 at Chemed, up from $4.1 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $13.3 million in Q1 2024, with the low at -$5.1 million in Q3 2022.
• Average Change in Accured Expenses over 5 years is $2.9 million, with a median of $3.0 million recorded in 2022.
• Across the five-year window, Change in Accured Expenses slumped 249.56% in 2022 and soared 605.47% in 2026, its largest moves.
• Year by year, Change in Accured Expenses stood at $3.2 million in 2022, then sank by 57.07% to $1.4 million in 2023, then surged by 219.84% to $4.4 million in 2024, then decreased by 7.54% to $4.1 million in 2025, then surged by 64.88% to $6.7 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $6.7 million, $4.1 million, and $4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.